Chronic cannabidiol treatment improves social and object recognition in double transgenic APPswe/PS1∆E9 mice
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Chronic cannabidiol treatment improves social and object recognition in double transgenic APPswe/PS1∆E9 mice
Authors
Keywords
Alzheimer’s disease, Novel therapeutic, Cannabidiol, Transgenic APP<sub>swe</sub>/PS1∆E9 mice, Cognition, Behaviour, Social recognition memory, Object recognition memory
Journal
PSYCHOPHARMACOLOGY
Volume 231, Issue 15, Pages 3009-3017
Publisher
Springer Nature
Online
2014-02-28
DOI
10.1007/s00213-014-3478-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Novel behavioural characteristics of the APPSwe/PS1ΔE9 transgenic mouse model of Alzheimer's disease
- (2013) David Cheng et al. BEHAVIOURAL BRAIN RESEARCH
- Inflammation and white matter degeneration persist for years after a single traumatic brain injury
- (2013) Victoria E. Johnson et al. BRAIN
- The anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis: involvement of the endocannabinoid system
- (2013) Alline C. Campos et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Comprehensive behavioral characterization of an APP/PS-1 double knock-in mouse model of Alzheimer's disease
- (2013) Scott J Webster et al. Alzheimers Research & Therapy
- The effect of ageing on neurogenesis and oxidative stress in the APPswe/PS1deltaE9 mouse model of Alzheimer's disease
- (2012) Alison Hamilton et al. BRAIN RESEARCH
- The therapeutic potential of the endocannabinoid system for Alzheimer's disease
- (2012) Tim Karl et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- In vivo hippocampal microdialysis reveals impairment of NMDA receptor–cGMP signaling in APPSW and APPSW/PS1L166P Alzheimer’s transgenic mice
- (2012) Malgorzata Duszczyk et al. NEUROCHEMISTRY INTERNATIONAL
- Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders
- (2012) A. C. Campos et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- Distinct Neurobehavioural Effects of Cannabidiol in Transmembrane Domain Neuregulin 1 Mutant Mice
- (2012) Leonora E. Long et al. PLoS One
- Role of Abca7 in Mouse Behaviours Relevant to Neurodegenerative Diseases
- (2012) Warren Logge et al. PLoS One
- Thy1-hAPPLond/Swe+mouse model of Alzheimer's disease displays broad behavioral deficits in sensorimotor, cognitive and social function
- (2012) Mehrdad Faizi et al. Brain and Behavior
- Cognition in female transmembrane domain neuregulin 1 mutant mice
- (2011) Rose Chesworth et al. BEHAVIOURAL BRAIN RESEARCH
- Cognitive phenotyping of amyloid precursor protein transgenic J20 mice
- (2011) Tim Karl et al. BEHAVIOURAL BRAIN RESEARCH
- Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress
- (2011) George W. Booz FREE RADICAL BIOLOGY AND MEDICINE
- Palmitoylethanolamide counteracts reactive astrogliosis induced by β-amyloid peptide
- (2011) Caterina Scuderi et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Cannabidiol and Other Cannabinoids Reduce Microglial Activation In Vitro and In Vivo: Relevance to Alzheimer's Disease
- (2011) A. M. Martin-Moreno et al. MOLECULAR PHARMACOLOGY
- Phytocannabinoids as novel therapeutic agents in CNS disorders
- (2011) Andrew J. Hill et al. PHARMACOLOGY & THERAPEUTICS
- Anomalies in social behaviors and exploratory activities in an APPswe/PS1 mouse model of Alzheimer's disease
- (2011) Mohammed Filali et al. PHYSIOLOGY & BEHAVIOR
- Cannabidiol Reduces Aβ-Induced Neuroinflammation and Promotes Hippocampal Neurogenesis through PPARγ Involvement
- (2011) Giuseppe Esposito et al. PLoS One
- Plasma and brain pharmacokinetic profile of cannabidiol (CBD), cannabidivarine (CBDV), Δ9-tetrahydrocannabivarin (THCV) and cannabigerol (CBG) in rats and mice following oral and intraperitoneal administration and CBD action on obsessive–compulsive behaviour
- (2011) Serena Deiana et al. PSYCHOPHARMACOLOGY
- Anxiogenic-like effects of chronic cannabidiol administration in rats
- (2011) Maha M. ElBatsh et al. PSYCHOPHARMACOLOGY
- Distribution patterns of cannabinoid CB1 receptors in the hippocampus of APPswe/PS1ΔE9 double transgenic mice
- (2010) Sara Kalifa et al. BRAIN RESEARCH
- Cannabinoid receptor CB1 mediates baseline and activity-induced survival of new neurons in adult hippocampal neurogenesis
- (2010) Susanne A Wolf et al. Cell Communication and Signaling
- ATP-binding Cassette Transporter A1 Mediates the Beneficial Effects of the Liver X Receptor Agonist GW3965 on Object Recognition Memory and Amyloid Burden in Amyloid Precursor Protein/Presenilin 1 Mice
- (2010) James J. Donkin et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Functional cholinergic damage develops with amyloid accumulation in young adult APPswe/PS1dE9 transgenic mice
- (2010) Eva Machová et al. NEUROBIOLOGY OF DISEASE
- Induced LC degeneration in APP/PS1 transgenic mice accelerates early cerebral amyloidosis and cognitive deficits
- (2010) Daniel Jardanhazi-Kurutz et al. NEUROCHEMISTRY INTERNATIONAL
- Cognition in transmembrane domain neuregulin 1 mutant mice
- (2010) L. Duffy et al. NEUROSCIENCE
- The interplay of cannabinoid and NMDA glutamate receptor systems in humans: Preliminary evidence of interactive effects of cannabidiol and ketamine in healthy human subjects
- (2010) Jaime E.C. Hallak et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Cannabidiol: A Promising Drug for Neurodegenerative Disorders?
- (2009) Teresa Iuvone et al. CNS Neuroscience & Therapeutics
- A 25-week, open-label trial investigating rivastigmine transdermal patches with concomitant memantine in mild-to-moderate Alzheimer’s disease: a post hoc analysis
- (2009) Martin R. Farlow et al. CURRENT MEDICAL RESEARCH AND OPINION
- A behavioural comparison of acute and chronic Δ9-tetrahydrocannabinol and cannabidiol in C57BL/6JArc mice
- (2009) Leonora E. Long et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb
- (2009) Angelo A. Izzo et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Inflammation and aging: Can endocannabinoids help?
- (2008) Yannick Marchalant et al. BIOMEDICINE & PHARMACOTHERAPY
- Behavioural profile of a new mouse model for NPY deficiency
- (2008) Tim Karl et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Memantine leads to behavioral improvement and amyloid reduction in Alzheimer's-disease-model transgenic mice shown as by micromagnetic resonance imaging
- (2008) Henrieta Scholtzova et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Animal models of Alzheimer's disease and frontotemporal dementia
- (2008) Jürgen Götz et al. NATURE REVIEWS NEUROSCIENCE
- GABAA Receptor-Mediated Acceleration of Aging-Associated Memory Decline in APP/PS1 Mice and Its Pharmacological Treatment by Picrotoxin
- (2008) Yuji Yoshiike et al. PLoS One
- Involvement of 5HT1A receptors in the anxiolytic-like effects of cannabidiol injected into the dorsolateral periaqueductal gray of rats
- (2008) Alline Cristina Campos et al. PSYCHOPHARMACOLOGY
- Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action
- (2008) Antonio Waldo Zuardi REVISTA BRASILEIRA DE PSIQUIATRIA
- Cannabidiol in vivo blunts β-amyloid induced neuroinflammation by suppressing IL-1β and iNOS expression
- (2007) G Esposito et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro
- (2007) A Thomas et al. BRITISH JOURNAL OF PHARMACOLOGY
- Activation of microglia by secreted amyloid precursor protein evokes release of glutamate by cystine exchange and attenuates synaptic function
- (2003) Steven W. Barger et al. JOURNAL OF NEUROCHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More